Method for the treatment of multiple sclerosis

作者: Bibiana Bielekova , Henry F. Mcfarland , Roland Martin

DOI:

关键词:

摘要: A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, provided that includes administering to the therapeutically effective amount of an IL-21 receptor antagonist, wherein has failed respond treatment beta interferon, thereby subject.

参考文章(94)
Ron Milo, Hillel Panitch, Glatiramer Acetate or Interferon-β for Multiple Sclerosis? CNS Drugs. ,vol. 11, pp. 289- 306 ,(1999) , 10.2165/00023210-199911040-00005
Ed Harlow, David Lane, Using Antibodies: A Laboratory Manual ,(1998)
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
John C. Kendrew, Eleanor Lawrence, The encyclopedia of molecular biology Blackwell Science. ,(1995)
Douglas Lake, Yasuhiko Masuho, Takashi Kawamura, Evan Hersh, Eskild Petersen, Yoh-ichi Matsumoto, Toru Sugano, Monoclonal antibodies specific for HIV and the hybridomas for production thereof ,(1994)
F Vandekerckhove, H Sobis, Ernest Meulepas, Herwig Carton, Alfons Billiau, Hubertine Heremans, R Dijkmans, Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. Journal of Immunology. ,vol. 140, pp. 1506- 1510 ,(1988)
Donald W. Mason, Antigen-antibody conjugates ,(1995)
Jose A. Frazao Moniz Pereira, Miguel A. Da Costa Garcia, Alcino Freitas Vieira, Paulo J. Da Silva Alves, Elsa M. Ribeiro Dos Santos-Anes, DNA INTEGRATION INTO 'MYCOBACTERIUM spp.' GENOME BY TRANS-COMPLEMENTATION USING A SITE-SPECIFIC INTEGRATION SYSTEM ,(1997)
Shiv Pillai, Abul K. Abbas, Andrew H. Lichtman, Cellular and Molecular Immunology ,(1994)